These observations suggested that the expression level of CKMT1A may serve as a crucial regulator in the progression of endometrial cancer as well as a novel therapeutic option for patients with endometrial cancer so as to improve prognosis and prevent tumor progression. This evidence concerns the gene CKMT1A and endometrial cancer.